ImmuCell Corporation Effective Income Tax Rate Reconciliation, Tax Credit, Percent
ImmuCell Corporation (ICCC) reported Effective Income Tax Rate Reconciliation, Tax Credit, Percent of 1.00% for the 9-month period ending 2025-09-30, per its 10-Q filed 2025-11-13.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationTaxCredits · last filed 2025-11-13
- ImmuCell Corporation effective income tax rate reconciliation, tax credit, percent for fiscal 2024 was 5.41%, a 488.04% increase from fiscal 2023.
- ImmuCell Corporation effective income tax rate reconciliation, tax credit, percent for fiscal 2023 was 0.92%, a 82.58% decline from fiscal 2022.
- ImmuCell Corporation effective income tax rate reconciliation, tax credit, percent for fiscal 2022 was 5.28%.
- ImmuCell Corporation effective income tax rate reconciliation, tax credit, percent for fiscal 2021 was -115.58%, a 2260.37% decline from fiscal 2020.
| Period end | Effective Income Tax Rate Reconciliation, Tax Credit, Percent 9 month | Effective Income Tax Rate Reconciliation, Tax Credit, Percent 12 month | Effective Income Tax Rate Reconciliation, Tax Credit, Percent 12 month as first filed |
|---|---|---|---|
| 2025-09-30 | 1.00% 10-Q · filed 2025-11-13 | ||
| 2024-12-31 | 5.41% 10-K · filed 2025-03-28 | ||
| 2024-09-30 | 1.00% 10-Q · filed 2025-11-13 | ||
| 2023-12-31 | 0.92% 10-K · filed 2025-03-28 | ||
| 2022-12-31 | 5.28% 10-K · filed 2024-04-01 | -5.28% 10-K · filed 2023-03-29 | |
| 2021-12-31 | -115.58% 10-K · filed 2023-03-29 | 115.58% 10-K · filed 2022-03-30 | |
| 2020-12-31 | 5.35% 10-K · filed 2022-03-30 | -5.35% 10-K · filed 2021-03-30 | |
| 2019-12-31 | -2.19% 10-K · filed 2021-03-30 | ||
| 2018-12-31 | -32.41% 10-K · filed 2020-03-27 | ||
| 2017-12-31 | -31.47% 10-K · filed 2019-03-22 | ||
| 2016-12-31 | -9.36% 10-K · filed 2018-03-29 | ||
| 2015-12-31 | -2.65% 10-K · filed 2017-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |